Kava + Enasidenib
Enasidenib brand name: Idhifa.
Enasidenib falls into 5 drug categories that Kava can interact with; the most serious is rated moderate. Theoretically, kava might increase levels of CYP2C19 substrates.
Read the full interaction reportKava and Enasidenib
These two interact in 5 distinct ways. Each one is explained separately below.
Why Are There 5 Interactions?
Kava interacts with whole categories of medication. Enasidenib falls into 5 of those categories, so it can interact with Kava in 5 different ways. We’ve listed each one below — your overall risk is driven by the most serious of them (Moderate).
CYTOCHROME P450 2C19 (CYP2C19) SUBSTRATES
1 of 5Why this applies to Enasidenib
Enasidenib falls under CYTOCHROME P450 2C19 (CYP2C19) SUBSTRATES — the group Kava interacts with.
In vitro research shows that kava significantly inhibits CYP2C19 enzymes. This effect has not yet been reported in humans.
Interaction has been documented in animal or in lab research, or the interaction has been documented in humans but is limited to case reports or conflicting clinical research exists.
Here's the situation with kava and your leukemia medicine, Idhifa (enasidenib). Lab studies show kava can block a liver enzyme called CYP2C19, which helps process certain drugs. In theory, slowing that enzyme could let enasidenib build up a bit higher in your body, possibly nudging up side effects like nausea, diarrhea, low appetite, or changes in your blood counts.
I want to be honest though: this is only seen in test-tube research, not in real patients, so we don't know if it actually happens in people. There's a bigger reason to be cautious here, both kava and enasidenib can stress the liver, so combining them isn't ideal. Please check with your oncology team or pharmacist before adding kava.
- Mathews JM, Etheridge AS, Black SR. Inhibition of human cytochrome P450 activities by kava extract and kavalactones. Drug Metab Dispos 2002;30:1153-7. PubMed
- Unger M, Frank A. Simultaneous determination of the inhibitory potency of herbal extracts on the activity of six major cytochrome P450 enzymes using liquid chromatography/mass spectrometry and automated online extraction. Rapid Commun Mass Spectrom 2004;1 PubMed
CYTOCHROME P450 2C9 (CYP2C9) SUBSTRATES
2 of 5Enasidenib also falls under CYTOCHROME P450 2C9 (CYP2C9) SUBSTRATES.
In vitro research shows that kava significantly inhibits CYP2C9 enzymes. This effect has not yet been reported in humans.
Interaction has been documented in animal or in lab research, or the interaction has been documented in humans but is limited to case reports or conflicting clinical research exists.
Here's the short version on combining kava with enasidenib (Idhifa). Your body uses a liver enzyme called CYP2C9 to help process enasidenib. In test-tube studies, kava appears to slow that enzyme down. If that happened in people, enasidenib could build up a bit more than expected, which in theory might mean stronger side effects like nausea, diarrhea, or worsening lab values such as bilirubin.
The important caveat: this is based only on lab research, not on real patients, so it's still theoretical. I'd also point out that kava itself can stress the liver, and enasidenib already requires liver monitoring, so that overlap is worth a conversation. Please don't start or stop anything on your own. Check with your oncology team or pharmacist first.
- Mathews JM, Etheridge AS, Black SR. Inhibition of human cytochrome P450 activities by kava extract and kavalactones. Drug Metab Dispos 2002;30:1153-7. PubMed
- Unger M, Frank A. Simultaneous determination of the inhibitory potency of herbal extracts on the activity of six major cytochrome P450 enzymes using liquid chromatography/mass spectrometry and automated online extraction. Rapid Commun Mass Spectrom 2004;1 PubMed
CYTOCHROME P450 1A2 (CYP1A2) SUBSTRATES
3 of 5Enasidenib also falls under CYTOCHROME P450 1A2 (CYP1A2) SUBSTRATES.
Although in vitro research and a case report suggest that kava inhibits CYP1A2, more robust clinical evidence shows that kava has no effect on CYP1A2. In a clinical study in healthy volunteers, taking kava 1000 mg twice daily (containing a daily dose of 138 mg kavalactones) for 28 days had no effect on CYP1A2 activity.
Interaction has been demonstrated in animal or in lab research but has been shown not to occur in humans..
Here's the short version: this is a pretty minor concern. Enasidenib (Idhifa) is handled in part by a liver enzyme called CYP1A2, and the worry on paper is that kava might slow that enzyme down, which could let a bit more of the drug build up. But the better-quality human research tells a calmer story. In one study, healthy people took a real kava dose for 28 days and saw no change in CYP1A2 activity, so any effect on enasidenib is unlikely.
The bigger thing I'd flag isn't this enzyme at all. Both kava and enasidenib can stress the liver, so stacking them may add up. If you're on enasidenib for your leukemia, please check with your oncology team or pharmacist before adding kava.
- Mathews JM, Etheridge AS, Black SR. Inhibition of human cytochrome P450 activities by kava extract and kavalactones. Drug Metab Dispos 2002;30:1153-7. PubMed
- Unger M, Frank A. Simultaneous determination of the inhibitory potency of herbal extracts on the activity of six major cytochrome P450 enzymes using liquid chromatography/mass spectrometry and automated online extraction. Rapid Commun Mass Spectrom 2004;1 PubMed
- Gurley BJ, Gardner SF, Hubbard MA, et al. In vivo effects of goldenseal, kava kava, black cohosh, and valerian on human cytochrome P450 1A2, 2D6, 2E1, and 3A4/5 phenotypes. Clin Pharmacol Ther 2005;77:415-26. PubMed
- Toohey TP, Lu BY, Wada C. Toxic effects of psychotropics related to possible p450 enzyme inhibition by kava:report of 2 cases. Prim Care Companion CNS Disord 2013;15(5). PubMed
- Asher GN, Corbett AH, Hawke RL. Common Herbal Dietary Supplement-Drug Interactions. Am Fam Physician. 2017;96(2):101-107.
CYTOCHROME P450 2D6 (CYP2D6) SUBSTRATES
4 of 5Enasidenib also falls under CYTOCHROME P450 2D6 (CYP2D6) SUBSTRATES.
In vitro research shows that kava extract significantly inhibits CYP2D6. However, clinical research shows that kava does not affect the metabolism of CYP2D6 substrates in humans.
Interaction has been demonstrated in animal or in lab research but has been shown not to occur in humans..
Here's the short version: the worry on paper is that kava might slow down a liver enzyme called CYP2D6, which in theory could let drugs handled by that enzyme build up a bit. But for enasidenib (Idhifa), this is really a minor, unlikely concern. While test-tube studies hinted that kava blocks CYP2D6, actual human studies showed kava did not meaningfully change how the body clears CYP2D6 drugs. So I wouldn't expect kava to make enasidenib stronger or its side effects (like nausea, low appetite, or rising bilirubin) noticeably worse through this pathway.
My bigger caution is liver health. Both kava and enasidenib can stress the liver, so please loop in your oncologist or pharmacist before adding kava.
- Mathews JM, Etheridge AS, Black SR. Inhibition of human cytochrome P450 activities by kava extract and kavalactones. Drug Metab Dispos 2002;30:1153-7. PubMed
- Unger M, Frank A. Simultaneous determination of the inhibitory potency of herbal extracts on the activity of six major cytochrome P450 enzymes using liquid chromatography/mass spectrometry and automated online extraction. Rapid Commun Mass Spectrom 2004;1 PubMed
- Gurley BJ, Gardner SF, Hubbard MA, et al. In vivo effects of goldenseal, kava kava, black cohosh, and valerian on human cytochrome P450 1A2, 2D6, 2E1, and 3A4/5 phenotypes. Clin Pharmacol Ther 2005;77:415-26. PubMed
- Gurley BJ, Swain A, Hubbard MA, et al. Clinical assessement of CYP2D6-mediated herb-drug interactions in humans: Effects of milk-thistle, black cohosh, goldenseal, kava kava, St. John's wort, and Echinacea. Mol Nutr Food Res 2008;52:755-63.
- Asher GN, Corbett AH, Hawke RL. Common Herbal Dietary Supplement-Drug Interactions. Am Fam Physician. 2017;96(2):101-107.
CYTOCHROME P450 3A4 (CYP3A4) SUBSTRATES
5 of 5Enasidenib also falls under CYTOCHROME P450 3A4 (CYP3A4) SUBSTRATES.
Although in vitro research suggests that kava inhibits CYP3A4, more robust clinical evidence shows that kava has no effect on CYP3A4. In a clinical study in healthy volunteers, taking kava 1000 mg twice daily (containing a daily dose of 138 mg kavalactones) for 28 days had no effect on CYP3A4 activity.
Interaction has been demonstrated in animal or in lab research but has been shown not to occur in humans..
Here's the practical bottom line for your leukemia medicine. Enasidenib (Idhifa) is processed in part by a liver enzyme called CYP3A4, and kava was once thought to slow that enzyme down based on test-tube studies. The worry was that kava might let enasidenib build up. But in real people, a careful clinical study found that kava did not actually change CYP3A4 activity. So this concern looks mostly theoretical, and a real interaction is considered unlikely and minor.
The bigger thing I'd flag is that kava itself has been tied to rare liver injury, and enasidenib already carries its own risks (including effects on liver and blood counts). Because of that overlap, please loop in your oncology team or pharmacist before adding kava.
- Mathews JM, Etheridge AS, Black SR. Inhibition of human cytochrome P450 activities by kava extract and kavalactones. Drug Metab Dispos 2002;30:1153-7. PubMed
- Unger M, Frank A. Simultaneous determination of the inhibitory potency of herbal extracts on the activity of six major cytochrome P450 enzymes using liquid chromatography/mass spectrometry and automated online extraction. Rapid Commun Mass Spectrom 2004;1 PubMed
- Gurley BJ, Gardner SF, Hubbard MA, et al. In vivo effects of goldenseal, kava kava, black cohosh, and valerian on human cytochrome P450 1A2, 2D6, 2E1, and 3A4/5 phenotypes. Clin Pharmacol Ther 2005;77:415-26. PubMed
- Asher GN, Corbett AH, Hawke RL. Common Herbal Dietary Supplement-Drug Interactions. Am Fam Physician. 2017;96(2):101-107.
What These Ratings Mean
Every interaction above is graded three ways — here’s the key to each label.
Clinically significant. Avoid the combination, or use only under close professional supervision.
Usually worth avoiding or managing — may need monitoring, a dose change, or timing apart.
Generally not serious. Be aware of it and mention it to your pharmacist.
- LikelyWell-controlled human studies have demonstrated the likely existence of this interaction.
- ProbableInteraction has not been documented in well-controlled studies, however, the interaction has been demonstrated in some small human studies or in controlled animal studies in conjunction with multiple case reports.
- PossibleInteraction has been documented in animal or in lab research, or the interaction has been documented in humans but is limited to case reports or conflicting clinical research exists.
- UnlikelyInteraction has been demonstrated in animal or in lab research but has been shown not to occur in humans.
- AHigh-quality meta-analysis (quantitative systematic review).
- BCase-control study.
- CConsensus.
- DAnecdotal evidence.
These ratings are for information only. Never start, stop, or otherwise change your therapy before speaking with your provider.
Kava Also Interacts With Other Medications
Kava has 248 major, 576 moderate, 341 minor known drug interactions in our database — the Enasidenib one above is among them. If you take anything else, check it against the full list below.
Check Another of Your Medications Against Kava
We haven’t checked that one against Kava yet — ask our pharmacists directly.
Covers the 2,830 medications we’ve checked against Kava. Pick one to open its full report.
See Every Supplement That Interacts With Enasidenib
This page covers Kava only. If you take other supplements — a multivitamin, a sleep aid, something for joints — the Enasidenib page lists 203 supplements it has a documented interaction with, worst first, each one explained.
The most serious there right now: Activated Charcoal (major), Grapefruit (major), St. John's Wort (major), 1,3-dmaa (moderate) and Acacia Rigidula (moderate).
By severity: 3 major · 156 moderate · 44 minor.
From our pharmacist’s overview on the Enasidenib page
“Anyone taking enasidenib (Idhifa) for acute myeloid leukemia should treat this supplement list with genuine care, beginning with the major-rated entries: grapefruit, St. John's wort, and activated charcoal.”
Reviewed by 2 · Jul 18, 2026
Taking Kava as Part of a Dietary Supplement Product? Check It for Interactions
We hold 403 real supplement products containing Kava, each one broken down to its full ingredient list — and combination products often carry several ingredients besides Kava. Your product may carry other ingredients that interact with Enasidenib too, on top of Kava — and those would not show on this page. Find your product and we’ll check every ingredient on its label:
Where Kava and Enasidenib Sit Against Everything Else
Out of every supplement and medication people look up on HelloPharmacist, here is where these two land this week — and which way each has been moving.
#291 of 1,452 supplements looked up here in the last 7 days
#2,242 of 2,830 medications looked up here in the last 7 days
Position among everything looked up on this site, not a measure of how commonly either one is used or how important it is. A supplement can climb this list because of a news story. It counts every request to the page, automated ones included, and nothing here identifies anyone.
About Kava
What is Kava?
- Anxiety and stress
- Restlessness
- Trouble sleeping
- Relaxation in social or cultural settings
- Menopausal symptoms
Kava is a Pacific Island plant traditionally used to promote relaxation and ease anxiety, and some studies suggest it may help mild anxiety. However, kava has been linked to rare but serious liver damage, so it should be used with caution, avoided by people with liver problems, and only used after talking with your pharmacist or doctor.
About Enasidenib
What Is Enasidenib Used For?
Brand name: Idhifa
Idhifa (enasidenib) is used to treat adult patients with acute myeloid leukemia (AML) — a fast-moving cancer of the blood and bone marrow — whose disease has come back after treatment (relapsed) or has stopped responding to treatment (refractory). It is specifically for patients whose leukemia has a mutation in the IDH2 gene, which must be confirmed by an FDA-approved test before starting therapy.
Other Drugs & Kava
Browse every other medication we’ve checked against Kava — both the ones with a known interaction and the ones without. Select any drug for the full detail.
No drugs match “”.
248 interactions
- Diphenhydramine ›
- Flurazepam ›
- Triazolam ›
- Zopiclone ›
- Fentanyl ›
- Oxycodone ›
- Phenytoin ›
- Temazepam ›
- Carbamazepine ›
- Morphine Sulfate ›
- Nitrazepam ›
- Buprenorphine ›
- Diazepam ›
- Lofepramine ›
- Meprobamate ›
- Oxymorphone ›
- Propoxyphene ›
- Topiramate ›
- Aripiprazole ›
- Cetirizine ›
- Clobazam ›
- Clonazepam ›
- Clorazepate ›
- Desipramine ›
- Doxepin ›
- Hydromorphone ›
- Levetiracetam ›
- Metoclopramide ›
- Midazolam ›
- Phenobarbital ›
- Tramadol ›
- Valproic Acid ›
- Zolpidem ›
- Acetazolamide ›
- Alprazolam ›
- Aripiprazole Lauroxil ›
- Buprenorphine Hydrochloride ›
- Butabarbital Sodium ›
- Chlorpromazine ›
- Dexmedetomidine ›
- Gabapentin ›
- Hexobarbital ›
- Hydrocodone ›
- Hydrocodone Bitartrate ›
- Lithium Carbonate (prescription Drug) ›
- Loxapine ›
- Magnesium Sulfate (prescription Drug) ›
- Meperidine ›
- Oxcarbazepine ›
- Oxycodone Hydrochloride ›
- Pregabalin ›
- Tasimelteon ›
- Zaleplon ›
- Zonisamide ›
- Acepromazine ›
- Alfentanil ›
- Aminoglutethimide ›
- Amitriptyline ›
- Amobarbital ›
- Brexanolone ›
Showing 60 of 248 major interactions — see all 248 on the Kava page.
576 interactions
- Diclofenac Sodium ›
- Diltiazem ›
- Nifedipine ›
- Ibuprofen ›
- Hydrocortisone ›
- Naproxen ›
- Doxycycline ›
- Erythromycin ›
- Estradiol ›
- Minocycline ›
- Propranolol ›
- Tetracycline ›
- Ranitidine ›
- Amoxicillin ›
- Testosterone ›
- Verapamil ›
- Fenofibrate ›
- Levonorgestrel ›
- Prednisone ›
- Quinidine ›
- Cyclosporine ›
- Dexamethasone ›
- Glyburide ›
- Methyltestosterone ›
- Ciprofloxacin ›
- Colchicine ›
- Flurbiprofen ›
- Prednisolone ›
- Triamcinolone ›
- Allopurinol ›
- Apomorphine ›
- Diclofenac Potassium ›
- Doxorubicin ›
- Formoterol ›
- Indomethacin ›
- Trimipramine ›
- Acetaminophen ›
- Conjugated Estrogens ›
- Everolimus ›
- Ivermectin ›
- Meloxicam ›
- Methotrexate ›
- Nitrofurantoin ›
- Ofloxacin ›
- Rifampin ›
- Testosterone Undecanoate ›
- Acarbose ›
- Betamethasone ›
- Cimetidine ›
- Dapsone ›
- Digoxin ›
- Doxycycline Hyclate ›
- Duloxetine ›
- Eltrombopag ›
- Erythromycin Ethylsuccinate ›
- Erythromycin Stearate ›
- Etoposide ›
- Interferon Alfa-2b ›
- Interferon Beta-1b ›
- Isoniazid ›
Showing 60 of 576 moderate interactions — see all 576 on the Kava page.
341 interactions
- Theophylline ›
- Lidocaine ›
- Norethindrone ›
- Oxybutynin ›
- Tacrolimus ›
- Budesonide ›
- Clindamycin ›
- Dextromethorphan ›
- Fluticasone ›
- Miconazole ›
- Amphetamine ›
- Ivabradine ›
- Medroxyprogesterone ›
- Medroxyprogesterone Acetate ›
- Nortriptyline ›
- Bendamustine ›
- Caffeine (otc Drug) ›
- Ciclesonide ›
- Cyclobenzaprine ›
- Fluphenazine ›
- Fluticasone Propionate ›
- Hydroxyzine ›
- Nicardipine ›
- Paroxetine ›
- Timolol ›
- Vortioxetine ›
- Almotriptan ›
- Amphetamine Sulfate ›
- Aprepitant ›
- Asenapine ›
- Budenoside ›
- Busulfan ›
- Cabazitaxel ›
- Caffeine (prescription Drug) ›
- Chlorpheniramine ›
- Clarithromycin ›
- Clozapine ›
- Cocaine Hydrochloride (prescription Drug) ›
- Dasatinib ›
- Desvenlafaxine ›
- Dexchlorpheniramine ›
- Dihydroergotamine ›
- Disopyramide Phosphate ›
- Ergotamine Tartrate (prescription Drug) ›
- Esterified Estrogens ›
- Felodipine ›
- Finasteride ›
- Flutamide ›
- Fluticasone Furoate ›
- Fosamprenavir ›
- Fosaprepitant ›
- Galantamine ›
- Irinotecan ›
- Metoprolol ›
- Mifepristone ›
- Mometasone ›
- Mometasone Furoate ›
- Nebivolol ›
- Nimodipine ›
- Pindolol ›
Showing 60 of 341 minor interactions — see all 341 on the Kava page.
No interaction 1,664 drugs checked — show the list
We also checked Kava against these medications and found no known interaction in our sources. Open any page to confirm.
- Levothyroxine ›
- Methylphenidate ›
- Aspirin ›
- Escitalopram ›
- Docusate ›
- Hydroxyurea ›
- Valacyclovir ›
- Tirzepatide ›
- Semaglutide ›
- Sumatriptan ›
- Metformin ›
- Lisinopril ›
- Bupropion ›
- Acyclovir ›
- Azithromycin ›
- Isotretinoin ›
- Methylene Blue ›
- Levothyroxine, Liothyronine ›
- Candesartan Cilexetil ›
- Cephalexin ›
- Cyclopentolate ›
- Roxithromycin ›
- Mannitol ›
- Pegunigalsidase Alfa-iwxj ›
- Ezetimibe ›
- Daptomycin ›
- Levothyroxine Sodium ›
- Dexmethylphenidate ›
- Mitomycin ›
- Spironolactone ›
- Hexobarbitone ›
- Thyroid Hormone ›
- Carbidopa, Levodopa ›
- Factor 7a ›
- Levodopa ›
- Hethylphenidate Hcl ›
- Minoxidil ›
- Cefaclor ›
- Azelaic Acid ›
- Phenylephrine ›
- Hydroxychloroquine ›
- Tenecteplase ›
- Dirithromycin ›
- Vancomycin ›
- Pizotifen ›
- Triptorelin ›
- Bentoquatam ›
- Acetylsalicylic Acid ›
- Ribavirin Aerosol ›
- Dextrothyroxine ›
- Procainamide ›
- Tocainide ›
- Rocuronium ›
- Telmisartan ›
- Hydrochlorothiazide ›
- Hydrochlorothiazide, Lisinopril ›
- Mitomycin C ›
- Lomustine ›
- Digitoxin ›
- Chenodiol ›
Showing the 60 most looked-up of 1,664 medications checked with no known interaction — see the full Kava list.
Sources & How We Checked
Interaction details are evidence-graded and sourced from the Natural Medicines database. The medication overview comes from MedlinePlus.
- Natural Medicines (Therapeutic Research Center) — Evidence-graded clinical reference for vitamins, herbs and supplements — the basis for our interaction data.
- MedlinePlus, U.S. National Library of Medicine — NIH consumer drug information, used for the medication overviews.
- NIH Dietary Supplement Label Database (DSLD) — Official supplement product labels.
Content is written and reviewed by licensed HelloPharmacist pharmacists. See our data sources and editorial standards for how this information is built and checked.
Parts of this content are provided by the Therapeutic Research Center, LLC.
DISCLAIMER: Currently this does not check for drug-drug interactions. This is not an all-inclusive comprehensive list of potential interactions and is for informational purposes only. Not all interactions are known or well-reported in the scientific literature, and new interactions are continually being reported. Input is needed from a qualified healthcare provider including a pharmacist before starting any therapy. Application of clinical judgment is necessary.
© 2021 Therapeutic Research Center, LLC
Taking Kava and Enasidenib Together: Common Questions
Can you take Kava with Enasidenib?
Why are there 5 interactions listed for Kava and Enasidenib?
How serious is the Kava and Enasidenib interaction?
Written and reviewed by the HelloPharmacist editorial staff. Our editorial policy
Still Have a Question About Enasidenib and Kava?
Our pharmacists answer your medication & supplement questions — free.
This information is for education only and is not a substitute for professional medical advice. Always check with your pharmacist or doctor before starting, stopping, or combining supplements and medications.